Kamada Ltd. (KMDA)
8.42
+0.18
(+2.18%)
USD |
NASDAQ |
Aug 24, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Kamada EPS Diluted (Quarterly) : 0.1605 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1605 |
| March 31, 2026 | 0.0716 |
| December 31, 2025 | 0.0578 |
| September 30, 2025 | 0.0918 |
| June 30, 2025 | 0.1283 |
| March 31, 2025 | 0.0689 |
| December 31, 2024 | 0.0662 |
| September 30, 2024 | 0.0672 |
| June 30, 2024 | 0.077 |
| March 31, 2024 | 0.0412 |
| December 31, 2023 | 0.088 |
| September 30, 2023 | 0.06 |
| June 30, 2023 | 0.0404 |
| March 31, 2023 | -0.0403 |
| December 31, 2022 | 0.0657 |
| September 30, 2022 | 0.0108 |
| June 30, 2022 | -0.0875 |
| March 31, 2022 | -0.0408 |
| December 31, 2021 | -0.1118 |
| September 30, 2021 | -0.0189 |
| June 30, 2021 | 0.0209 |
| March 31, 2021 | 0.0601 |
| December 31, 2020 | 0.0364 |
| September 30, 2020 | 0.1535 |
| June 30, 2020 | 0.0777 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.12 |
| December 31, 2019 | 0.1329 |
| September 30, 2019 | 0.1446 |
| March 31, 2019 | 0.1223 |
| December 31, 2018 | 0.4406 |
| September 30, 2018 | -0.0594 |
| June 30, 2018 | 0.1412 |
| March 31, 2018 | 0.0312 |
| December 31, 2017 | 0.16 |
| September 30, 2017 | -0.01 |
| June 30, 2017 | 0.13 |
| March 31, 2017 | -0.11 |
| December 31, 2016 | -0.05 |
| September 30, 2016 | -0.03 |
| June 30, 2016 | -0.04 |
| March 31, 2016 | -0.06 |
| December 31, 2015 | 0.03 |
| September 30, 2015 | -0.13 |
| June 30, 2015 | -0.06 |
| March 31, 2015 | -0.15 |
| December 31, 2014 | 0.05 |
| September 30, 2014 | -0.08 |
| June 30, 2014 | -0.23 |
| March 31, 2014 | -0.09 |
| December 31, 2013 | 0.04 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLineRx Ltd. | -0.5804 |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | -2.318 |
| Revium Recovery, Inc. | -0.0096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.262M |
| Revenue (Quarterly) | 54.92M |
| Total Expenses (Quarterly) | 45.66M |
| Enterprise Value | 417.07M |
| Gross Profit Margin (Quarterly) | 40.91% |
| Profit Margin (Quarterly) | 16.86% |
| Earnings Yield | 4.53% |
| Operating Earnings Yield | 5.63% |
| Normalized Earnings Yield | 4.651 |